BCL2 and polycystic ovary syndrome: The expression of Bcl-2 gene was significantlyelevated in the PCOS group (P=0.007), it significantly decreased in the groups treatedwith 100 mg/kg BP (P=0.007), 200 mg/kg BP (P=0.007), MET (P<0.01), and combinationof MET and BP (50,100 and 200 mg/kg, P<0.01) compared to the PCOS group(Fig.4B).